More News
7 January 2021
Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies7 January 2021
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs6 January 2021
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy6 January 2021
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors30 December 2020
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK080428 December 2020
f5 Therapeutics Announces Seed Investment to Advance Targeted Protein Degrader Platform NExMods™23 December 2020
Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health23 December 2020
ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company22 December 2020
Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer22 December 2020
XPose Therapeutics and Accelero Biostructures announce Joint Research Collaboration for the Discovery and Development of Novel Cancer Therapies22 December 2020
Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System22 December 2020
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders22 December 2020
Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs18 December 2020
ONK Therapeutics Announces Three Exclusive Option License Agreements, Which Extend and Strengthen its Dual-Targeted NK Cell Therapy Pipeline18 December 2020
Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases18 December 2020
Leading BioSciences and Seneca Biopharma Announce Merger16 December 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics14 December 2020
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-197112 December 2020
AstraZeneca to acquire Alexion, accelerating the Company’s strategic and financial development10 December 2020
Gilead Sciences to Acquire MYR GmbHNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports